Blogs
Stay ahead with expert insights, emerging trends, and practical tips. Dive into our blog for innovative strategies and fresh perspectives.
Featured | Private Equity
Biopharma VC in 2Q25: Capital Concentrates in De-Risked Assets
Biopharma venture capital (VC) dealmaking slowed sharply in 2Q25, with investment consolidating into select, larger transactions targeting lower-risk opportunities. Investors are prioritizing clinically validated assets, AI-enabled R&D models, and M&A-driven exits over speculative...
Read More
